H.R. 7017

Referred to Committee

Right to Test Act

Introduced 5/26/2020•116th Congress•House

Congress.gov

Latest Action

Referred to the House Committee on Energy and Commerce.

5/26/2020 • House

Summary

Right to Test Act

This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency.

Unless requested by the governor of the state, the Food and Drug Administration (FDA) may not, during the emergency, engage in certain enforcement actions related to such a test or device.

Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.

Introduced in House • 5/26/2020

Enter your district to see how this bill affects your community

Topics & Subjects

Policy Area: Health

Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careHealth technology, devices, suppliesInfectious and parasitic diseasesMedical tests and diagnostic methodsState and local government operations